Cancer cells excel at evading detection, but subtle chemical differences set them apart from healthy cells. Now, a team of ...

For the millions of people living with genetic diseases like muscular dystrophy and inherited liver disorders, one of the ...

The global cell therapy technologies market is set to grow from USD 4.41 billion in 2025 to USD 7.91 billion by 2030, ...

A research team has discovered an enhanced CRISPR gene-editing system that could enable targeted delivery inside the human ...

A compact Cas12f nuclease shows high editing efficiency in human cells, with structural insights enabling an engineered variant potentially suited for future AAV‑compatible delivery.

Scientists have taken an important step toward a gene therapy that could one day turn off the extra genetic material that ...

NIH-funded UT team and colleagues from Metagenomi Thereapeutics discovered highly efficient enzyme could enable targeted gene editing within the human body.

“While recent single-cell multiomics studies and CRISPR screens in murine NK cells have expanded our understanding, actionable genomic targets in primary human NK cells have remained largely ...

Next-generation cell therapies are reshaping therapeutics by precisely engineering living cells for both ex vivo and in vivo applications. Cutting-edge tools—including Cas enzymes (Cas9, Cas12a), base ...

Stem cells hold a tremendous amount of research promise. At one time, obtaining them seemed to be a nearly insurmountable challenge, until a process was invented by Gladstone Senior Investigator ...